wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Editorial staff
     Editorial board
     For authors
Allergology Review

 Search in articles:
  Authority of Polish Society of Allergology

vol 11. no 1. March 2006  

 Clinical immunology
Biologicals used in psoriasis treatment
Marta Woźniak, Roman Nowicki

The treatment of psoriasis, which is in fact an immunological disease, continues to be a major therapeutical problem. The patients affected with that chronic disease have been waiting for better and more effective treatment. The introduction of new biological drugs may bring a breakthrough in psoriasis treatment. Four new biologicals have been reported: efalizumab, alefacept, etanercept and infliximab, which for a short time have been used in psoriasis treatment. The results show that the advanced and chronic symptoms disappear completely, and the biologicals are characterised by high efficiency in the treatment of the resistant and the advanced forms of psoriasis. A review of literature on the new biological drugs is included.

keywords: łuszczyca, efalizumab, alefacept, infliksimab, etanercept, psoriasis, efalizumab, alefacept, infliximab, etanercept

pages: from 29 to 34

estimated time of download (127 kB)
broadband speed:561282565121024[kbps]

You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.

Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2021 Mediton Publishing House | All rights reserved.